Robert Eibl

Dr. Robert Eibl

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1993 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
HOHiroko Ohgaki
Hiroko Ohgaki
RERobert Eibl
Robert Eibl
MRMartin B. Reichel
Martin B. Reichel
LMLuigi Mariani
Luigi Mariani
IPIver Petersen
Iver Petersen
MGManuela Gehring
Manuela Gehring

1 January 1993 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Closed access
PDF file
DLDavid N. Louis
David N. Louis
ADAndreas Von Deimling
Andreas Von Deimling
RCRichard Y. Chung
Richard Y. Chung
MRMari-Paz Rubio
Mari-Paz Rubio
JWJean M. Whaley
Jean M. Whaley
BSBernd R. Seizinger
Bernd R. Seizinger
The p53 gene is a tumor suppressor gene involved in many common malignancies, including astrocytomas. Genetic analysis of the p53

4 May 1995 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
IPIlka Preuss
Ilka Preuss
IEIngrid Eberhagen
Ingrid Eberhagen
SHSimone Haas
Simone Haas
RERobert Eibl
Robert Eibl
MKManfred Kaufmann
Manfred Kaufmann
BKBernd Kaina
Bernd Kaina

29 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
RERobert Eibl
Robert Eibl
MSMarkus Schneemann
Markus Schneemann
Two decades of “promising results” in liquid biopsy have led to both continuing disappointment and hope that the new era of minimally invasive, personalized analysis can be applied for better diagnosis, prognosis, monitoring, and therapy of cancer. Here, we briefly highlight the promises, developments, and challenges related to liquid biopsy of brain tumors, including circulating tumor cells, cell-free nucleic acids, extracellular vesicles, and miRNA; we further discuss the urgent need to establish suitable biomarkers and the right standards to improve modern clinical management of brain tumor patients with the use of liquid biopsy.

15 May 1992
Verified
Journal Article
Closed access
ADA Von Deimling
A Von Deimling
RERobert Eibl
Robert Eibl
HOH Ohgaki
H Ohgaki
DLD N Louis
D N Louis
KAK Von Ammon
K Von Ammon
BSB R Seizinger
B R Seizinger

31 May 2005 in The Analyst
Verified
Journal Article
Closed access
PDF file
MPMarkus Pax
Markus Pax
JRJanosch Rieger
Janosch Rieger
RERobert Eibl
Robert Eibl
CTChristiane Thielemann
Christiane Thielemann
DJDiethelm Johannsmann
Diethelm Johannsmann
The quartz crystal microbalance (QCM) was used to study the variability of acoustic properties of living cells on the sub-second time scale. A confluent cell layer of rat cardiac myocytes was grown onto the electrode of quartz crystal resonator. The cell layer performed periodic, synchronous contractions at a rate of about 1.5 Hz. In order to monitor these rather fast changes in the state of the cells, the QCM was operated in a “fast mode”, which allows sampling of the shift of the resonance frequency and energy dissipation with a rate of up to 100 Hz. The contractions were clearly reflected in periodic variations of the resonance frequency and the bandwidth. The rate of the contractions, in particular, could be easily detected in this way. Building on the rate of contraction, the setup can be used to monitor the response of the cell layer to heart stimulating drugs like isoproterenol. Depending on the concentration of isoproterenol, the beat rate was found to increase by up to a factor of two.